310 results match your criteria: "Tufts Medical Center and Tufts University School of Medicine.[Affiliation]"

After allogeneic HSCT (allo-HSCT), the diversity of the intestinal microbiota significantly decreases. The changes can be rapid and are thought to be caused by chemotherapy, antibiotics, or intestinal inflammation. Most patients are exposed to prophylactic and therapeutic antibiotics during neutropenia and several patients are colonized by ESBL bacteria.

View Article and Find Full Text PDF

Purpose: Neuropathic corneal pain (NCP) has been recognized as a distinct disease, yet treatment options remain limited. The aim of this pilot study was to explore the effectiveness of extranasal neurostimulation (EXNS) as a potential pain relief strategy for individuals with the peripheral component of NCP.

Methods: A retrospective study was performed to identify patients who were diagnosed with refractory peripheral or mixed NCP and subsequently underwent a single session of EXNS.

View Article and Find Full Text PDF

Blueprint for Building and Sustaining a Cardiogenic Shock Program: Qualitative Survey of 12 US Programs.

J Soc Cardiovasc Angiogr Interv

November 2024

Center for Cardiovascular Analytics, Research + Data Science (CARDS), Providence Heart Institute, Providence Research Network, Portland, Oregon.

Background: Multidisciplinary cardiogenic shock (CS) programs have been associated with improved outcomes, yet practical guidance for developing a CS program is lacking.

Methods: A survey on CS program development and operational best practices was administered to 12 institutions in diverse sociogeographic regions and practice settings. Common steps in program development were identified.

View Article and Find Full Text PDF

Background: Clinical genetic evaluation of dilated cardiomyopathy (DCM) is implemented variably or not at all. Identifying needs and barriers to genetic evaluations will enable strategies to enhance precision medicine care.

Methods: An online survey was conducted in June 2024 among cardiologist investigators of the DCM Consortium from US advanced heart failure/transplant (HF/TX) programs to collect demographics, training, program characteristics, genetic evaluation practices for DCM, and implementation needs.

View Article and Find Full Text PDF

Background: Accounting for race and ethnicity in estimating disease risk may improve the accuracy of predictions but may also encourage a racialized view of medicine.

Objective: To present a decision analytic framework for considering the potential benefits of race-aware over race-unaware risk predictions, using cardiovascular disease, breast cancer, and lung cancer as case studies.

Design: Cross-sectional study.

View Article and Find Full Text PDF

Physiological Pacing for the Prevention and Treatment of Heart Failure: a State-of-the-Art Review.

J Card Fail

December 2024

University of Vermont Larner College of Medicine, Department of Medicine, Burlington, VT, USA; Lillehei Heart Institute, University of Minnesota College of Medicine, Minneapolis, MN, USA. Electronic address:

Permanent pacing from the right ventricular apex can reduce quality of life and increase the risk of heart failure and death. This review summarizes the milestones in the evolution of pacemakers toward physiological pacing with biventricular pacing systems and lead implantation into the cardiac conduction system to synchronize cardiac contraction and relaxation. Both approaches aim to reproduce normal cardiac activation and help to prevent and treat heart failure.

View Article and Find Full Text PDF

Heart failure with preserved ejection fraction (HFpEF) and atrial fibrillation (AF) are comorbid conditions that are increasingly prevalent and have a high socioeconomic burden. This article discusses their shared pathophysiology, focusing on the triad of hypertension, obesity, and aging. We highlight the misperception that pharmacological heart rate lowering is beneficial, which has resulted in an overprescription of β-blockers in HFpEF and AF.

View Article and Find Full Text PDF

Measuring Symptoms Across the Spectrum of Chronic Kidney Disease: Strategies for Incorporation Into Kidney Care.

Semin Nephrol

October 2024

External Relations and Patient Engagement, Kidney Research Institute/Center for Dialysis Innovation, Division of Nephrology, Department of Medicine, University of Washington, Seattle, WA.

Many people across the spectrum of chronic kidney disease (CKD) experience a large symptom burden. Measuring symptoms can be a way of responding to the concerns of patients and their priorities of care and may help to improve overall outcomes, including health-related quality of life. The objective of this article is to discuss approaches to measuring symptoms across the spectrum of CKD and to highlight strategies to facilitate the incorporation of routine symptom assessment into kidney care.

View Article and Find Full Text PDF

Wildland firefighters (WLFFs) experience lung function decline due to occupational exposure to fire smoke. WLFFs typically do not wear respiratory personal protective equipment, and if they do, it is a simple bandana, which is not effective at filtering smoke. To pinpoint the biological underpinnings of abnormal respiratory function following 3-7 years of WLFF service, we exposed mice to Douglas fir smoke (DFS) over 8 weeks.

View Article and Find Full Text PDF

The Need to Adapt the Psychiatric Clinical Assessment to the Digital Age: A Practical Approach.

Psychiatr Serv

September 2024

Department of Psychiatry, Yale School of Medicine, New Haven (Moreno); Department of Psychiatry, Vagelos College of Physicians and Surgeons, Columbia University, and New York State Psychiatric Institute, New York City (Dixon, Jankowski, Erlich, First); Department of Psychiatry, Tufts Medical Center and Tufts University School of Medicine, Boston (Adler); Canyon Manor Mental Health Rehabilitation Center, Novato, California (Berlant); Geisel School of Medicine, Hanover, and Dartmouth Institute, Lebanon, New Hampshire (Brunette); Department of Psychiatry, Jane and Terry Semel Institute for Neuroscience and Human Behavior, and David Geffen School of Medicine, Center for Social Medicine and Humanities, University of California Los Angeles, Los Angeles (Castillo); Department of Psychiatry and Behavioral Sciences, Stanford University, Palo Alto, California (Edwards); Department of Psychiatry and Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto (Kozloff); Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia (Oslin, Talley); U.S. Department of Veterans Affairs, Corporal Michael J. Crescenz Medical Center, Philadelphia (Oslin); Department of Psychiatry, Donna and Barbara Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York (Siris).

The use of electronic devices and social media is becoming a ubiquitous part of most people's lives. Although researchers are exploring the sequelae of such use, little attention has been given to the importance of digital media use in routine psychiatric assessments of patients. The nature of technology use is relevant to understanding a patient's lifestyle and activities, the same way that it is important to evaluate the patient's occupation, functioning, and general activities.

View Article and Find Full Text PDF

Employer-Sponsored Health Insurance Premium Cost Growth and Its Association With Earnings Inequality Among US Families.

JAMA Netw Open

January 2024

Food Is Medicine Institute, Friedman School of Nutrition Science and Policy, Tufts University, Boston, Massachusetts.

Importance: Costs of employer-sponsored health care benefits have increased faster than workers' wages for several decades, with important implications for disparities in earnings and wage stagnation.

Objective: To quantify how growth in employer-sponsored health insurance (ESI) premiums may have been associated with reduced annual wages, disparities in earnings by race and ethnicity and wage level, and wage stagnation among US families with ESI.

Design, Setting, And Participants: In this economic evaluation, serial cross-sectional analyses were performed of US families receiving ESI from 1988 to 2019 based on data from the Consumer Expenditure Survey, Kaiser Employer Health Benefits Survey, US Census Bureau's Current Population Survey, and federal payroll taxation rates.

View Article and Find Full Text PDF

Aim: Emerging evidence suggests a beneficial effect of higher heart rates in some patients with heart failure with preserved ejection fraction (HFpEF). This study aimed to evaluate the impact of higher backup pacing rates in HFpEF patients with preexisting pacemaker systems that limit pacemaker-mediated dyssynchrony across left ventricular (LV) volumes and LV ejection fraction (LVEF).

Methods And Results: This is a post-hoc analysis of the myPACE clinical trial that evaluated the effects of personalized accelerated pacing setting (myPACE) versus standard of care on changes in Minnesota Living with Heart Failure Questionnaire (MLHFQ) score, N-terminal pro-brain natriuretic peptide (NT-proBNP), pacemaker-detected activity levels, and atrial fibrillation (AF) burden in patients with HFpEF with preexisting pacemakers.

View Article and Find Full Text PDF

Recent surveys show rising numbers of young people who report anxiety and depression. Although much attention has focused on mental health of adolescent youth, less attention has been paid to young people as they transition into adulthood. Multiple factors may have contributed to this steady increase: greater exposure to social media, information, and distressing news via personal electronic devices; increased concerns regarding social determinants of health and climate change; and changing social norms due to increased mental health literacy and reduced stigma.

View Article and Find Full Text PDF

Personalized accelerated physiologic pacing.

Eur Heart J Suppl

November 2023

Department of Medicine, Larner College of Medicine, University of Vermont, Burlington, 111 Colchester Avenue, McClure Level 1, Burlington, VT 05401, USA.

Heart failure with preserved ejection fraction (HFpEF) is increasingly prevalent with a high socioeconomic burden. Pharmacological heart rate lowering was recommended to improve ventricular filling in HFpEF. This article discusses the misperceptions that have resulted in an overprescription of beta-blockers, which in all likelihood have untoward effects on patients with HFpEF, even if they have atrial fibrillation or coronary artery disease as a comorbidity.

View Article and Find Full Text PDF
Article Synopsis
  • Focused cardiac ultrasound (FoCUS) is increasingly used in clinical practice, but there is limited research on its use with artificial intelligence (AI) for assessing left ventricular ejection fraction (LVEF).
  • A study with 449 participants compared AI-assisted LVEF assessments using FoCUS by novice and experienced users against traditional transthoracic echocardiograms (TTE), finding excellent agreement in outcomes and high accuracy for identifying abnormal heart function.
  • The results indicated that FoCUS AI-assisted assessments generated reliable LVEF estimates across user experience levels, making it a promising tool for diverse clinical settings.
View Article and Find Full Text PDF

Our drug development process has produced many life-saving medications, but patients experiencing rare diseases and similar conditions often are left with limited options for treatment. For an approved treatment to be developed, research on a new candidate or existing drug must validate safety and efficacy based on contemporary research expectations. Randomized clinical trials are conducted for this purpose, but they are also costly, laborious, and time-consuming.

View Article and Find Full Text PDF

Rare Variant Genetics and Dilated Cardiomyopathy Severity: The DCM Precision Medicine Study.

Circulation

September 2023

The Davis Heart and Lung Research Institute (G.J.H., E.J., J.C., D.D.K., H.N., R.E.H.), Department of Internal Medicine, The Ohio State University, Columbus.

Article Synopsis
  • The study investigates the genetic factors associated with advanced dilated cardiomyopathy (DCM), particularly focusing on rare genetic variants related to patients requiring devices like left ventricular assist devices (LVAD) or heart transplants (HT).
  • Researchers analyzed data from a diverse group of 1,198 patients enrolled in a precision medicine study, classifying the severity of DCM based on treatment type and assessing genetic variants in 36 related genes.
  • Findings revealed that 26.2% of patients with advanced DCM (LVAD/HT) had pathogenic genetic variants, significantly more than those with only an implantable cardioverter defibrillator (15.9%) or neither treatment (15.0%), indicating a strong genetic link to
View Article and Find Full Text PDF

Assessing the impact of grief on quality of life, work productivity, and health outcomes for parents bereaved from SMA: A study protocol.

Cost Eff Resour Alloc

August 2023

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA.

Background: U.S. cost-effectiveness recommendations suggest that analyses should include all costs and effects relevant to the decision problem [1].

View Article and Find Full Text PDF

Background: Persons with well-treated human immunodeficiency virus (HIV) demonstrate a 2-fold higher risk of cardiovascular disease (CVD), which may be related to excess visceral adipose tissue (VAT). The visceral adiposity index (VAI) is a score to approximate VAT by combining biochemical measures with anthropometrics without quantification by imaging. We evaluated VAI in association with cardiometabolic factors among persons with HIV (PWH).

View Article and Find Full Text PDF
Article Synopsis
  • - The study investigates the genetic differences in dilated cardiomyopathy (DCM) among Black, Hispanic, and White patients, noting that Black patients face higher familial risk and worse health outcomes compared to White patients, despite most existing genetic data coming from the latter group.
  • - Researchers conducted a cross-sectional study involving over 1,000 patients across various US heart failure centers, focusing on genetic variants in 36 DCM-related genes, classified based on their significance and clinical impact.
  • - Findings revealed that Black patients displayed a lower percentage of clinically actionable genetic variants compared to White patients (8.2% vs 25.5%), particularly in the TTN gene, highlighting potential disparities in genetic influences on DCM severity among different ances
View Article and Find Full Text PDF